ClinicalTrials.gov
ClinicalTrials.gov Menu

A Comparison Between Glargine and Detemir Insulin in Type 2 Diabetes

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00457093
Recruitment Status : Completed
First Posted : April 5, 2007
Last Update Posted : November 18, 2010
Sponsor:
Collaborator:
Novo Nordisk A/S
Information provided by:
Diabetes Care Center

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : No date given
  Actual Study Completion Date : May 2007
Publications:
Russell-Jones, D. et al. Diabetologia 2002;45(Suppl. 2):A51
King, AB, Armstrong, DU. Presentation at Diabetes Technology & Therapeutics Meeting, 2003, San Francisco
Heise, T et al. Diabetes 2003;52(Suppl.1):A121